| 注册
首页|期刊导航|中国药理学通报|细胞因子类抗糖尿病药物研究进展

细胞因子类抗糖尿病药物研究进展

周庆峰

中国药理学通报2016,Vol.32Issue(6):760-763,4.
中国药理学通报2016,Vol.32Issue(6):760-763,4.DOI:10.3969/j.issn.1001-1978.2016.06.005

细胞因子类抗糖尿病药物研究进展

Research progress in anti-diabetic drugs of cytokine

周庆峰1

作者信息

  • 1. 商丘师范学院生命科学学院,生物技术药物重点实验室,河南商丘 476000
  • 折叠

摘要

Abstract

Cytokine(CK)is a kind of low molecular weight solu-ble protein induced by immunogen,mitogen and other irritant a-gents,and is used widely in the field of diseases.Recently,a series of cytokines with anti-diabetic function such as fibroblast growth factors,adipocytokines,intestinal cytokines,epidermal growth factor were subsequently reported.Anti-diabetic drugs of cytokine have been paid much more attention to due to their less adverse reactions,the success of these researches will provide more ways for the treatment of diabetes.This article summarizes the progress in the research and development of anti-diabetic drugs of cell factor.

关键词

细胞因子/糖尿病/血糖/不良反应/药物/研究进展

Key words

cytokine/diabetes/blood glucose/adverse reac-tions/drug/research progress

分类

医药卫生

引用本文复制引用

周庆峰..细胞因子类抗糖尿病药物研究进展[J].中国药理学通报,2016,32(6):760-763,4.

基金项目

国家自然科学基金资助项目(No 30901877);河南省高等学校重点科研项目 ()

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文